Connection

Joseph John to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Joseph John has written about Antibodies, Monoclonal.
Joseph John
Connection Strength
0.281
Antibodies, Monoclonal
  1. Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60.
    View in: PubMed
    Score: 0.225
  2. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug; 50(8):2751-5.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.